Literature DB >> 12704608

Regression methods for assessing familial aggregation of disease.

Nan M Laird1, Karen T Cuenco.   

Abstract

This paper reviews methods for assessing familial aggregation of disease based on simple logistic regression models. Studies are based on a case-control sampling design, where the disease status of the first degree relatives of both cases and controls are obtained. Both 'proband predictive' and 'family predictive' models are discussed, and an example is given using a case-control sample from a lung cancer study in non-smokers. The methods are extended to characterize co-aggregation of two disorders, that is, presence of one disorder in the proband increases the risk of a second disorder in the relative. An example involving eating disorders and depression is given. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12704608     DOI: 10.1002/sim.1504

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  Analysis of familial aggregation studies with complex ascertainment schemes.

Authors:  Abigail G Matthews; Dianne M Finkelstein; Rebecca A Betensky
Journal:  Stat Med       Date:  2008-10-30       Impact factor: 2.373

2.  Fitting ACE structural equation models to case-control family data.

Authors:  K N Javaras; J I Hudson; N M Laird
Journal:  Genet Epidemiol       Date:  2010-04       Impact factor: 2.135

3.  Choline transporter gene variation is associated with attention-deficit hyperactivity disorder.

Authors:  Brett A English; Maureen K Hahn; Ian R Gizer; Michelle Mazei-Robison; Angela Steele; Daniel M Kurnik; Mark A Stein; Irwin D Waldman; Randy D Blakely
Journal:  J Neurodev Disord       Date:  2009-08-28       Impact factor: 4.025

4.  Multivariate logistic regression for familial aggregation in age at disease onset.

Authors:  Abigail G Matthews; Dianne M Finkelstein; Rebecca A Betensky
Journal:  Lifetime Data Anal       Date:  2007-04-05       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.